Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7680
+0.0160 (2.12%)
Jul 11, 2025, 12:59 PM - Market open
Nautilus Biotechnology Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Nautilus Biotechnology stock has a target of 1.75, which predicts a 127.88% increase from the current stock price of 0.77.
Price Target: $1.75 (+127.88%)
Analyst Consensus: Strong Sell
* Price targets were last updated on Dec 5, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Nautilus Biotechnology is "Strong Sell". This means that the analyst believes this stock is likely to have very poor returns in the near future.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $2.25 → $1.75 | Hold → Strong Sell | Downgrades | $2.25 → $1.75 | +127.88% | Dec 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +681.30% | Jun 27, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Initiates $5 → $3 | Strong Buy → Hold | Initiates | $5 → $3 | +290.65% | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $6 | Hold | Reiterates | $6 | +681.30% | Aug 3, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +681.30% | Aug 3, 2022 |
Financial Forecast
Revenue This Year
n/a
from 67.12M
Revenue Next Year
n/a
EPS This Year
-0.61
from -0.56
EPS Next Year
-0.71
from -0.61
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 5.3M | 11.0M | ||
| Avg | n/a | 2.6M | 10.7M | ||
| Low | n/a | n/a | 10.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 332.4% | ||
| Avg | - | - | 320.0% | ||
| Low | - | - | 303.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.58 | -0.65 | -0.69 |
| Avg | -0.61 | -0.71 | -0.67 |
| Low | -0.64 | -0.75 | -0.65 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.